ENT devices include cochlear implants (Cochlear, Advanced Bionics, MED-EL), bone-anchored hearing systems, hypoglossal nerve stimulation for sleep apnea (Inspire), sinus balloons, and image-guided sinus and skull-base surgery systems. Products include cochlear implants, hearing aids, sinus devices and airway tools. FDA created an over-the-counter hearing aid category in 2022. Cochlear implants are Class III and need PMA approval.

Why it matters

Inspire's hypoglossal nerve stimulator opened a large addressable market for moderate-to-severe OSA in CPAP-intolerant patients.

Common pitfalls

•Misclassifying an ENT device can lead to incorrect regulatory pathways and delays in market access.
•Failing to consider the unique cybersecurity risks associated with connected ENT devices can result in patient harm and non-compliance with standards like IEC 81001-5-1.
•Ignoring post-market surveillance requirements for ENT devices can lead to undetected safety issues and regulatory penalties.
•Not adequately addressing usability during the design of ENT devices can result in user error and adverse events.

Sources

AAO-HNS · AAO-HNS
MedTech Europe - Facts & Figures · MedTech Europe
MedTech Dive · MedTech Dive
Ophthalmic, anesthesia, respiratory, ENT and dental devices · U.S. Food and Drug Administration (FDA)

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.